In a report released yesterday, Elizabeth Anderson CFA from Evercore ISI maintained a Hold rating on Charles River Labs (CRL – Research ...

Have you looked into how Charles River Laboratories (CRL) performed internationally during the quarter ending December 2024? Considering the widespread global presence of this medical research ...

Omeros Corporation's stock surges as narsoplimab data shows 68% lower death risk in HSCT-TMA patients. Click to learn about the potential and risks of OMER stock.

Charles River Laboratories International Inc (NYSE:CRL) reported fourth-quarter 2024 revenue of $1 billion, a decrease of 1.1 ...

The first test train has completed its first trip through the full length of the $5.5 billion City Rail Link - two months ...

J.P. Morgan analyst Casey Woodring maintained a Hold rating on Charles River Labs (CRL – Research Report) yesterday and set a price target of ...

Grant Cook’s family were devastated by his death and have received an out-of-court settlement after suing the ruling body.

Charles River Laboratories International, Inc. CRL reported fourth-quarter 2024 adjusted earnings per share (EPS) of $2.66, ...

Last year, the commission’s report found that racism was prevalent in Phoenix, negatively impacting the lives of African ...

As promised, the restructuring initiatives taking place at Charles River Labs (NYSE: CRL) have resulted in a reduced ...

Analysts have set 12-month price targets for Charles River, revealing an average target of $185.0, a high estimate of $210.00 ...

Minister Simeon Brown emphasized that CRL will be a game-changer for Auckland’s public transport system. “The first train ...